Cured
Cured is a technology company.
Financial History
Cured has raised $13.0M across 2 funding rounds.
Frequently Asked Questions
How much funding has Cured raised?
Cured has raised $13.0M in total across 2 funding rounds.
Cured is a technology company.
Cured has raised $13.0M across 2 funding rounds.
Cured has raised $13.0M in total across 2 funding rounds.
Cured is a healthcare technology company founded in 2018 that builds a digital marketing and CRM platform powered by AI and real-time data to enhance patient engagement, unify workflows, and drive revenue growth for healthcare organizations.[1][2][3][5] It serves health systems, providers, and organizations by solving fragmented patient outreach, disconnected tools, and poor care experiences through automated campaigns, audience building, insights, and performance reporting—resulting in metrics like increased scheduled appointments and patient interactions.[1][5] Acquired and operating as a subsidiary of Innovaccer, Cured has raised $12.5M–$67.5M total, employs around 33 people, and maintains strong growth momentum with partnerships at top health systems like UCHealth.[1][2][4]
Cured was co-founded in 2018 in Indianapolis, Indiana (with teams in Boulder, Chicago, and San Francisco) by Sawyer (CEO, from GE Ventures), Ashmer (CTO, ex-Salesforce Principal Enterprise Architect and Accenture consultant, started at Epic Systems), and Rohit (Chief Customer Officer, ex-Salesforce Principal Solution Engineer and Epic Application Director).[1][3] The trio, with 35+ years combined at health tech leaders like Epic and Salesforce, met in 2008 at Epic during a major tech shift in healthcare; they launched Cured to apply proven CRM/marketing automation from other industries to healthcare's complexities.[1][3] Early traction came fast: within six months of founding, three top health systems provided feedback to refine the MVP, focusing on real patient experience over fragmented tools.[1] This execution-driven culture—prioritizing speed, clinical workflows, and retention—propelled Cured to acquisition by Innovaccer while earning trust from leading providers.[1]
Cured stands out in healthcare tech through these key strengths:
Cured rides the wave of AI-driven patient engagement and personalized healthcare, capitalizing on post-pandemic shifts toward digital consumer relationships in a $4T+ U.S. industry fragmented by siloed systems.[1][3][5] Timing aligns with rising demands for data unification amid value-based care, consumerized health experiences, and CRM adoption—mirroring B2C successes but adapted for regulations and workflows.[1][2] Market tailwinds include healthcare's tech maturation (e.g., Epic/Salesforce integrations) and AI scalability for outcomes/revenue, positioning Cured to influence ecosystems by enabling providers to compete on engagement like retail brands.[1][3][5] As an Innovaccer subsidiary, it amplifies broader data activation trends, helping systems retain patients and grow amid consolidation.[1]
Cured's trajectory points to expanded AI capabilities and deeper Innovaccer synergies, scaling its platform to more health systems amid AI healthcare boom—potentially hitting new revenue highs via global outreach and advanced predictive analytics.[1][5] Trends like personalized medicine, telehealth integration, and regulatory pushes for outcomes will fuel growth, evolving Cured from niche CRM to essential experience layer.[3][5] Its influence may grow by setting standards for "sticky" tech that outlasts hype, turning data into sustained competitive edges for providers—echoing its founding bet on execution over ego for lasting patient impact.[1]
Cured has raised $13.0M in total across 2 funding rounds.
Cured's investors include Bread and Butter Ventures, Company Ventures, DNA Capital, Dynamo Ventures, Forum Ventures, Founders Fund, Foundry Group, Giant Ventures, High Alpha, LAUNCHub Ventures, Matchstick Ventures, Motivate Ventures.
Cured has raised $13.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2021 | $10.0M Series A | Bread and Butter Ventures, Company Ventures, DNA Capital, Dynamo Ventures, Forum Ventures, Founders Fund, Foundry Group, Giant Ventures, High Alpha, LAUNCHub Ventures, Matchstick Ventures, Motivate Ventures, Revolution Ventures, SOSV, SVG Ventures-THRIVE, Techstars, VMG Partners, Allison Barr Allen, Andrew Bialecki, Daniel Rothman, Daren Cotter, Jamie Sutton, Jonathan Bradford, Peter Bodenheimer, Ron Pragides, Todd Ruppert | |
| Sep 1, 2019 | $3.0M Seed | Bread and Butter Ventures, Company Ventures, DNA Capital, Dynamo Ventures, Forum Ventures, Founders Fund, Foundry Group, Giant Ventures, High Alpha, LAUNCHub Ventures, Matchstick Ventures, Motivate Ventures, Revolution Ventures, SOSV, SVG Ventures-THRIVE, Techstars, VMG Partners, Allison Barr Allen, Andrew Bialecki, Daniel Rothman, Daren Cotter, Jamie Sutton, Jonathan Bradford, Peter Bodenheimer, Ron Pragides, Todd Ruppert |